Advantis Corporation (ADVT) is focused on helping people take control of their health and pain management needs. By creating strategic partnerships with innovative companies in the nutraceutical and alternative health care industries, Advantis is uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Acquiring ownership in developing companies allows Advantis to provide consultation to improve product lines, expand distribution channels, and heighten brand value. With the healthcare and pain management sectors forecasting staggering growth, Advantis identifies and partners with those companies that possess the potential to capitalize on this trend.
Acquisitions and product developments ensure that Advantis reaches sustainable revenue growth in the near-term as it prepares for future market opportunities. CEO, Christopher Swartz envisions the success of Advantis Corporation through strengthened partnerships, innovative product development, and sustained focus on revenue-producing strategies. With the help of a diverse and skilled management team, Swartz has navigated Advantis towards enhancing its footprint in the evolving legal cannabis business, holistic pain management, and healthcare industries. Expertise in the legal aspects of the medical cannabis industry allows Advantis to work within the framework of the law to target opportunities along the supply-chain of this untapped, explosive growth industry.
SEQUENCE THERAPY + FITNESS
Advantis Corp. recently acquired a 25% stake in Sequence Therapy, LLC. The company has an established client base of physicians and pain management specialists it works with to research and develop innovative techniques to treat the source of pain, rather than the symptoms. A laboratory gymnasium is maintained to study, educate, license and develop pain management techniques for patients and physicians to utilize. Sequence Therapy has developed an application over the past 10 years that it provides to health care professionals (under licensing agreement) that prescribe sequence therapy exercises for chronic pain.
Treatment of chronic pain is a $560 billion industry because physicians often use highly addictive opiates to treat the symptoms of pain, which usually exacerbates the problem. Sequence Therapy believes there is a better way. The company is developing non-addictive CBD (a cannabis extract) formulae that can be paired with sequenced therapy programs that can aid the execution of exercises targeting the source of chronic pain. Using the natural pain suppressant along with prescribed exercises will allow patients to safely reduce and in some cases rid themselves of chronic pain, without the damaging side effects of opiates.The company currently earns $500,000 in annual revenue from its existing client base; Advantis is executing a strategy to exponentially increase revenue through targeted marketing, branding, and distribution channels.
Oregon Advantis Cannabis, Washington Advantis Cannabis
Advantis Corp strives to be at the forefront of the coming “Green Rush”. Formed in 2015, Oregon Advantis Cannabis LLC and Washington Advantis Cannabis LLC are in the final stages of solidifying relationships with current producers and distributors of cannabis with the intent to acquire a majority share and controlling interest.
LipMed RX Anti-Flu & Cold Lip Balm Protectant fights and kills Flu and Cold Germs on the lips before they enter the mouth, while moisturizing and soothing the lips to prevent dryness and chapping. Laboratory tested and proven to kill 99.9% of the influenza germ and fights off the rhinovirus germ and bacteria to prevent a cold.
CleanVD® is the first all-in-one at home test kit for HIV, Herpes, Hepatitis, Chlamydia, Syphilis, & Human Papillomavirus (HPV). It’s completely private. And it’s based on the same tests that healthcare professionals have used for years.
Natural Elements, Inc. is a non-profit, mutual benefit corporation that operates in accordance with California Health & Safety Sec. 11362(B)(1)(A) & 11362.7(H) Prop 215 S.B. 420. We are dedicated to providing a high quality and efficient, medical marijuana delivery service to all of our patients. Specializing in locally grown organic medicines, and edible products, we serve all qualified patients.
Market Value: $4,098,608 a/o Jun 02, 2016
Authorized Shares: 1,000,000,000 a/o Jan 01, 2016
Outstanding Shares: 788,193,875 a/o Jan 01, 2016
Float: 189,431,544 a/o Jan 01, 2016
Par Value: 0.0001
Shareholders of Record: 423 a/o Jan 01, 2016
Short Interest: 0 (-100%) Apr 14, 2016
Transfer Agent: Pacific Stock Transfer Co.
Chris Swartz: CEO
John Bowman: CFO, Accountant
6 Hutton Center Drive
Santa Ana, CA 92707